# Dinghang Capital

> Dinghang Capital is a VC fund backing Health Care, Medical and Pharmaceutical. See 6 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Total investments: 6
- Last investment: Feb 2026
- Lead investor: 17%
- Last updated: Aug 2026
- Website: http://dinghongcapital.com

Dinghang Capital is a VC fund focused on Health Care and Medical. Dinghang Capital provides investors with professional asset management services.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 3 | 50% |
| Medical | 2 | 33% |
| Pharmaceutical | 2 | 33% |
| Aerospace | 1 | 17% |
| Life Science | 1 | 17% |

9 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 2 | 33% |
| Funding Round | 2 | 33% |
| Series B | 1 | 17% |
| Venture - Series Unknown | 1 | 17% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Zhuzhou Hongxing Technology | Zhuzhou Hongxing Technology focuses on the engineering application of pulsed plasma thrusters. |  | Seed | Feb 10, 2026 |  |
| Shengjisheng Semiconductor | Shengjisheng Semiconductor is committed to facilitating the localization of vital semiconductor machinery. It offers technical assistance and replacement parts associated with the production of semiconductors. |  | Venture - Series Unknown | Dec 07, 2023 |  |
| META Pharmaceuticals | META Pharmaceuticals is a cutting-edge drug development company specializing in autoimmune diseases. | $15M | Seed | Jun 13, 2022 |  |
| MGI Tech | MGI Tech is committed to enabling effective and affordable healthcare solutions for all. MGI produces sequencing devices, equipment, consumables and reagents to support life science research, medicine and healthcare. MGI’s multi-omics platforms include genetic sequencing, mass spectrometry and medical imaging. Providing real-time, comprehensive,life-long solutions, its mission is to advance life science tools and lead digital health innovation. | $1B | Series B | May 28, 2020 |  |
| iRegene | iRegene researches and develops pharmaceutical therapy for neurodegenerative and rare diseases. |  |  | Jan 01, 2020 |  |
| WuXi Biologics | WuXi Biologics is a open-access technology platform company offering end-to-end solutions to empower organizations to discover, develop, and manufacture biologics from concept to commercial manufacturing. Across the global biologics research and development community, we enable our partners to find innovative biological treatments for diseasesworldwide. |  |  | Jan 01, 2017 |  |

6 of 6 investments shown.

## Co-investors
- [BGI Co-Win](https://shizune.co/investors/profile/bgi-co-win) — VC Fund, 1 deal together
- [CPE Capital](https://shizune.co/investors/profile/champ-private-equity) — VC Fund, 1 deal together
- [CITIC Securities](https://shizune.co/investors/profile/citic-securities) — VC Fund, 1 deal together
- [Cornerstone Capital](https://shizune.co/investors/profile/cornerstone-capital-6cb9) — VC Fund, 1 deal together
- [Cornerstone Capital](https://shizune.co/investors/profile/cornerstone-capital-913b) — VC Fund, 1 deal together
- [Co-Stone Venture Capital](https://shizune.co/investors/profile/co-stone-capital) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Dinghang Capital invest in?

Dinghang Capital invests primarily in Health Care, Medical and Pharmaceutical startups, most often at Seed and Funding Round stage. Most of the 6 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Dinghang Capital last invest?

The most recent investment recorded for Dinghang Capital closed in Feb 2026. Shizune tracks 6 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co